Skip to main content
. 2022 Jun 22;12:10517. doi: 10.1038/s41598-022-14351-2

Table 2.

Sensitivity of compared assays at 50, 100 and 150 days from symptom onset.

Survival probability (95% CI)
50-day 100-day 150-day
Abbott-N 0.985 (0.97;0.99) 0.919 (0.89;0.95) 0.655 (0.6;0.71)
Roche-N 0.988 (0.98;1.0) 0.963 (0.94;0.98) 0.949 (0.92;0.97)
Roche-S 0.991 (0.98;1.0) 0.966 (0.95;0.99) 0.952 (0.93;0.98)
MSD
N 0.988 (0.98;1.0) 0.972 (0.95;0.99) 0.907 (0.87;0.94)
S 0.997 (0.99;1.0) 0.978 (0.96;0.99) 0.968 (0.95;0.99)
RBD 0.994 (0.99;1.0) 0.969 (0.95;0.99) 0.909 (0.88;0.94)